EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Zynex's enterprise value is $389.5 Mil.
Zynex's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $17.9 Mil. Therefore, Zynex's EV-to-EBITDA for today is 21.77.
The historical rank and industry rank for Zynex's EV-to-EBITDA or its related term are showing as below:
ZYXI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -61.79 Med: 11.76 Max: 69.07
Current: 21.77
During the past 13 years, the highest EV-to-EBITDA of Zynex was 69.07. The lowest was -61.79. And the median was 11.76.
ZYXI's EV-to-EBITDA is ranked worse than 90.12% of 81
companies
in the Medical Distribution industry
Industry Median: 9.95
vs ZYXI: 21.77
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-27), Zynex's stock price is $11.21.
Zynex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.260. Therefore, Zynex's PE Ratio for today is 43.12.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Zynex EV-to-EBITDA Historical Data
The historical data trend for Zynex's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Zynex's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zynex's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zynex's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Zynex's EV-to-EBITDA falls into.
Zynex's current Enterprise Value is $389.5 Mil.
Zynex's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zynex (NAS:ZYXI) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Zynex's share price for today is $11.21.
Zynex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.260.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Zynex's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZYXI has been successfully added to your 